GB2625089A - Method and system for making gummy consumables containing functional ingredients - Google Patents
Method and system for making gummy consumables containing functional ingredients Download PDFInfo
- Publication number
- GB2625089A GB2625089A GB2218250.5A GB202218250A GB2625089A GB 2625089 A GB2625089 A GB 2625089A GB 202218250 A GB202218250 A GB 202218250A GB 2625089 A GB2625089 A GB 2625089A
- Authority
- GB
- United Kingdom
- Prior art keywords
- gummy
- solution
- functional ingredients
- functional
- gummy base
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004615 ingredient Substances 0.000 title claims abstract description 169
- 238000000034 method Methods 0.000 title claims abstract description 41
- 239000000243 solution Substances 0.000 claims abstract description 114
- 239000003349 gelling agent Substances 0.000 claims abstract description 38
- 238000000151 deposition Methods 0.000 claims abstract description 24
- 238000004519 manufacturing process Methods 0.000 claims abstract description 20
- 238000002347 injection Methods 0.000 claims abstract description 19
- 239000007924 injection Substances 0.000 claims abstract description 19
- 238000005086 pumping Methods 0.000 claims abstract description 5
- 239000007788 liquid Substances 0.000 claims description 43
- 230000008021 deposition Effects 0.000 claims description 15
- 235000015872 dietary supplement Nutrition 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 229920002472 Starch Polymers 0.000 claims description 12
- 229920000159 gelatin Polymers 0.000 claims description 12
- 235000019322 gelatine Nutrition 0.000 claims description 12
- 235000019698 starch Nutrition 0.000 claims description 12
- 108010010803 Gelatin Proteins 0.000 claims description 11
- 235000011852 gelatine desserts Nutrition 0.000 claims description 11
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 11
- 235000010755 mineral Nutrition 0.000 claims description 11
- 239000011707 mineral Substances 0.000 claims description 11
- 229940088594 vitamin Drugs 0.000 claims description 11
- 239000011782 vitamin Substances 0.000 claims description 11
- 239000008273 gelatin Substances 0.000 claims description 10
- 239000006041 probiotic Substances 0.000 claims description 10
- 235000018291 probiotics Nutrition 0.000 claims description 10
- 229930003231 vitamin Natural products 0.000 claims description 10
- 235000013343 vitamin Nutrition 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 9
- 150000001720 carbohydrates Chemical class 0.000 claims description 7
- 235000014633 carbohydrates Nutrition 0.000 claims description 7
- 239000003086 colorant Substances 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 7
- 229920001277 pectin Polymers 0.000 claims description 7
- 235000010987 pectin Nutrition 0.000 claims description 7
- 239000001814 pectin Substances 0.000 claims description 7
- 235000013406 prebiotics Nutrition 0.000 claims description 7
- 102000004190 Enzymes Human genes 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000000465 moulding Methods 0.000 claims description 6
- 235000000346 sugar Nutrition 0.000 claims description 6
- 229920001817 Agar Polymers 0.000 claims description 5
- 235000010419 agar Nutrition 0.000 claims description 5
- 235000019568 aromas Nutrition 0.000 claims description 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 5
- 235000018102 proteins Nutrition 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 235000003599 food sweetener Nutrition 0.000 claims description 4
- 229940088597 hormone Drugs 0.000 claims description 4
- 239000005556 hormone Substances 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 239000003921 oil Substances 0.000 claims description 3
- 235000020374 simple syrup Nutrition 0.000 claims description 3
- 150000005846 sugar alcohols Chemical class 0.000 claims description 3
- 150000008163 sugars Chemical class 0.000 claims description 3
- 239000003765 sweetening agent Substances 0.000 claims description 3
- 238000012546 transfer Methods 0.000 claims description 3
- 241000206672 Gelidium Species 0.000 claims description 2
- 229920002148 Gellan gum Polymers 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 235000010980 cellulose Nutrition 0.000 claims description 2
- 230000015556 catabolic process Effects 0.000 abstract description 6
- 238000006731 degradation reaction Methods 0.000 abstract description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 40
- 239000000203 mixture Substances 0.000 description 29
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 18
- 229930003268 Vitamin C Natural products 0.000 description 18
- 235000019154 vitamin C Nutrition 0.000 description 18
- 239000011718 vitamin C Substances 0.000 description 18
- 235000009508 confectionery Nutrition 0.000 description 16
- 239000012467 final product Substances 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 10
- 239000008107 starch Substances 0.000 description 10
- 230000000529 probiotic effect Effects 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 108090000765 processed proteins & peptides Proteins 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- 229940088598 enzyme Drugs 0.000 description 6
- -1 for example Substances 0.000 description 6
- 241000894006 Bacteria Species 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 239000000416 hydrocolloid Substances 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 235000010205 Cola acuminata Nutrition 0.000 description 4
- 244000228088 Cola acuminata Species 0.000 description 4
- 244000194101 Ginkgo biloba Species 0.000 description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000011669 selenium Substances 0.000 description 4
- 229910052711 selenium Inorganic materials 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 241000218671 Ephedra Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 238000010411 cooking Methods 0.000 description 3
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 3
- 235000018417 cysteine Nutrition 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 235000015203 fruit juice Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000036642 wellbeing Effects 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N 2,3,4,5-tetrahydroxypentanal Chemical compound OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241001608472 Bifidobacterium longum Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 235000015438 Cola nitida Nutrition 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- 208000002064 Dental Plaque Diseases 0.000 description 2
- 244000133098 Echinacea angustifolia Species 0.000 description 2
- 241001632410 Eleutherococcus senticosus Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 241000735432 Hydrastis canadensis Species 0.000 description 2
- 235000017309 Hypericum perforatum Nutrition 0.000 description 2
- 244000141009 Hypericum perforatum Species 0.000 description 2
- 229920001202 Inulin Polymers 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 2
- 229920000881 Modified starch Polymers 0.000 description 2
- 239000004368 Modified starch Substances 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 244000151637 Sambucus canadensis Species 0.000 description 2
- 235000018735 Sambucus canadensis Nutrition 0.000 description 2
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 2
- 244000078534 Vaccinium myrtillus Species 0.000 description 2
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 2
- 235000013832 Valeriana officinalis Nutrition 0.000 description 2
- 244000126014 Valeriana officinalis Species 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003316 Vitamin D Natural products 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229940009291 bifidobacterium longum Drugs 0.000 description 2
- 235000007123 blue elder Nutrition 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 235000014134 echinacea Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000007124 elderberry Nutrition 0.000 description 2
- 239000008769 eleutheroside Substances 0.000 description 2
- 229930190029 eleutheroside Natural products 0.000 description 2
- 235000008995 european elder Nutrition 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 2
- 229940107187 fructooligosaccharide Drugs 0.000 description 2
- 235000013376 functional food Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 229930182494 ginsenoside Natural products 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 235000005679 goldenseal Nutrition 0.000 description 2
- 239000012676 herbal extract Substances 0.000 description 2
- 229940029339 inulin Drugs 0.000 description 2
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000003050 macronutrient Effects 0.000 description 2
- 235000021073 macronutrients Nutrition 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 235000019426 modified starch Nutrition 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 235000017807 phytochemicals Nutrition 0.000 description 2
- 229930000223 plant secondary metabolite Natural products 0.000 description 2
- 238000001243 protein synthesis Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- ULSUXBXHSYSGDT-UHFFFAOYSA-N tangeretin Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 ULSUXBXHSYSGDT-UHFFFAOYSA-N 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 125000002640 tocopherol group Chemical class 0.000 description 2
- 235000019149 tocopherols Nutrition 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 230000014616 translation Effects 0.000 description 2
- 235000016788 valerian Nutrition 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 229940046008 vitamin d Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- YEFOAORQXAOVJQ-UHFFFAOYSA-N wuweizischun A Natural products C1C(C)C(C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-UHFFFAOYSA-N 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 description 1
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- JBYXPOFIGCOSSB-GOJKSUSPSA-N 9-cis,11-trans-octadecadienoic acid Chemical compound CCCCCC\C=C\C=C/CCCCCCCC(O)=O JBYXPOFIGCOSSB-GOJKSUSPSA-N 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000208874 Althaea officinalis Species 0.000 description 1
- 235000006576 Althaea officinalis Nutrition 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 235000007320 Avena fatua Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 241001647031 Avena sterilis Species 0.000 description 1
- 235000004535 Avena sterilis Nutrition 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 206010070545 Bacterial translocation Diseases 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241000186018 Bifidobacterium adolescentis Species 0.000 description 1
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- DNJVYWXIDISQRD-UHFFFAOYSA-N Cafestol Natural products C1CC2(CC3(CO)O)CC3CCC2C2(C)C1C(C=CO1)=C1CC2 DNJVYWXIDISQRD-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 1
- 240000008886 Ceratonia siliqua Species 0.000 description 1
- 240000003538 Chamaemelum nobile Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 235000000228 Citrus myrtifolia Nutrition 0.000 description 1
- 240000003791 Citrus myrtifolia Species 0.000 description 1
- 235000016646 Citrus taiwanica Nutrition 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 241001574013 Collogenes Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 235000002787 Coriandrum sativum Nutrition 0.000 description 1
- 244000018436 Coriandrum sativum Species 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 241000938605 Crocodylia Species 0.000 description 1
- 241001648652 Croton ovalifolius Species 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 239000004321 EU approved sweetener Substances 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- 241000490050 Eleutherococcus Species 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000006587 Glutathione peroxidase Human genes 0.000 description 1
- 108700016172 Glutathione peroxidases Proteins 0.000 description 1
- 108010015899 Glycopeptides Proteins 0.000 description 1
- 102000002068 Glycopeptides Human genes 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 235000008694 Humulus lupulus Nutrition 0.000 description 1
- 244000025221 Humulus lupulus Species 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 241001468157 Lactobacillus johnsonii Species 0.000 description 1
- 241000186605 Lactobacillus paracasei Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 102000003792 Metallothionein Human genes 0.000 description 1
- 108090000157 Metallothionein Proteins 0.000 description 1
- 235000009811 Momordica charantia Nutrition 0.000 description 1
- 244000302512 Momordica charantia Species 0.000 description 1
- 235000009421 Myristica fragrans Nutrition 0.000 description 1
- 240000009023 Myrrhis odorata Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- FFDGPVCHZBVARC-UHFFFAOYSA-N N,N-dimethylglycine Chemical compound CN(C)CC(O)=O FFDGPVCHZBVARC-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- ZIKZPLSIAVHITA-UHFFFAOYSA-N Nomilinic acid Natural products CC(=O)OC(CC(O)=O)C1(C)C(C(C)(C)O)CC(=O)C(C23OC2C(=O)O2)(C)C1CCC3(C)C2C=1C=COC=1 ZIKZPLSIAVHITA-UHFFFAOYSA-N 0.000 description 1
- BZQFBWGGLXLEPQ-UHFFFAOYSA-N O-phosphoryl-L-serine Natural products OC(=O)C(N)COP(O)(O)=O BZQFBWGGLXLEPQ-UHFFFAOYSA-N 0.000 description 1
- 235000010676 Ocimum basilicum Nutrition 0.000 description 1
- 240000007926 Ocimum gratissimum Species 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 240000005859 Orthosiphon aristatus Species 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 240000003444 Paullinia cupana Species 0.000 description 1
- 235000000556 Paullinia cupana Nutrition 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 108010001441 Phosphopeptides Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 235000016787 Piper methysticum Nutrition 0.000 description 1
- 240000005546 Piper methysticum Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ORNBQBCIOKFOEO-YQUGOWONSA-N Pregnenolone Natural products O=C(C)[C@@H]1[C@@]2(C)[C@H]([C@H]3[C@@H]([C@]4(C)C(=CC3)C[C@@H](O)CC4)CC2)CC1 ORNBQBCIOKFOEO-YQUGOWONSA-N 0.000 description 1
- CWEZAWNPTYBADX-UHFFFAOYSA-N Procyanidin Natural products OC1C(OC2C(O)C(Oc3c2c(O)cc(O)c3C4C(O)C(Oc5cc(O)cc(O)c45)c6ccc(O)c(O)c6)c7ccc(O)c(O)c7)c8c(O)cc(O)cc8OC1c9ccc(O)c(O)c9 CWEZAWNPTYBADX-UHFFFAOYSA-N 0.000 description 1
- MOJZMWJRUKIQGL-FWCKPOPSSA-N Procyanidin C2 Natural products O[C@@H]1[C@@H](c2cc(O)c(O)cc2)Oc2c([C@H]3[C@H](O)[C@@H](c4cc(O)c(O)cc4)Oc4c3c(O)cc(O)c4)c(O)cc(O)c2[C@@H]1c1c(O)cc(O)c2c1O[C@@H]([C@H](O)C2)c1cc(O)c(O)cc1 MOJZMWJRUKIQGL-FWCKPOPSSA-N 0.000 description 1
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 1
- 235000019904 Raftiline® Nutrition 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000235070 Saccharomyces Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 206010039921 Selenium deficiency Diseases 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- IECRXMSGDFIOEY-UHFFFAOYSA-N Tangeretin Natural products COC=1C(OC)=C(OC)C(OC)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C=C1 IECRXMSGDFIOEY-UHFFFAOYSA-N 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 241001473768 Ulmus rubra Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 229960004308 acetylcysteine Drugs 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 239000001068 allium cepa oil Substances 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000002882 anti-plaque Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 229940127088 antihypertensive drug Drugs 0.000 description 1
- 239000002579 antinauseant Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000007375 bacterial translocation Effects 0.000 description 1
- 229940038481 bee pollen Drugs 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229940009289 bifidobacterium lactis Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000037180 bone health Effects 0.000 description 1
- 235000019835 bromelain Nutrition 0.000 description 1
- DNJVYWXIDISQRD-JTSSGKSMSA-N cafestol Chemical compound C([C@H]1C[C@]2(C[C@@]1(CO)O)CC1)C[C@H]2[C@@]2(C)[C@H]1C(C=CO1)=C1CC2 DNJVYWXIDISQRD-JTSSGKSMSA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 229940108924 conjugated linoleic acid Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 239000000850 decongestant Substances 0.000 description 1
- 229940124581 decongestants Drugs 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229950006137 dexfosfoserine Drugs 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002059 diagnostic imaging Methods 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 108700003601 dimethylglycine Proteins 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 229940066493 expectorants Drugs 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 125000004387 flavanoid group Chemical group 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000010647 garlic oil Substances 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000010224 hepatic metabolism Effects 0.000 description 1
- CKAPSXZOOQJIBF-UHFFFAOYSA-N hexachlorobenzene Chemical compound ClC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl CKAPSXZOOQJIBF-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 238000009925 jellying Methods 0.000 description 1
- 108010083502 kappa-caseinoglycopeptide Proteins 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 150000002664 lycopenes Chemical class 0.000 description 1
- 239000001115 mace Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000001035 marshmallow Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000020727 milk thistle extract Nutrition 0.000 description 1
- 229940096421 milk thistle extract Drugs 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 230000002232 neuromuscular Effects 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- KPDOJFFZKAUIOE-WNGDLQANSA-N nomilin Chemical compound C=1([C@H]2[C@]3(C)CC[C@H]4[C@@]([C@@]53O[C@@H]5C(=O)O2)(C)C(=O)C[C@H]2C(C)(C)OC(=O)C[C@@H]([C@]42C)OC(=O)C)C=COC=1 KPDOJFFZKAUIOE-WNGDLQANSA-N 0.000 description 1
- KPDOJFFZKAUIOE-HPFWCIFASA-N nomilin Natural products O=C(O[C@H]1[C@@]2(C)[C@@H](C(C)(C)OC(=O)C1)CC(=O)[C@]1(C)[C@@H]2CC[C@@]2(C)[C@H](c3cocc3)OC(=O)[C@@H]3O[C@@]123)C KPDOJFFZKAUIOE-HPFWCIFASA-N 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- CKNAQFVBEHDJQV-UHFFFAOYSA-N oltipraz Chemical compound S1SC(=S)C(C)=C1C1=CN=CC=N1 CKNAQFVBEHDJQV-UHFFFAOYSA-N 0.000 description 1
- 229950008687 oltipraz Drugs 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 229940055729 papain Drugs 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- FDIKHVQUPVCJFA-UHFFFAOYSA-N phosphohistidine Chemical compound OP(=O)(O)NC(C(=O)O)CC1=CN=CN1 FDIKHVQUPVCJFA-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- BZQFBWGGLXLEPQ-REOHCLBHSA-N phosphoserine Chemical compound OC(=O)[C@@H](N)COP(O)(O)=O BZQFBWGGLXLEPQ-REOHCLBHSA-N 0.000 description 1
- USRGIUJOYOXOQJ-GBXIJSLDSA-N phosphothreonine Chemical compound OP(=O)(O)O[C@H](C)[C@H](N)C(O)=O USRGIUJOYOXOQJ-GBXIJSLDSA-N 0.000 description 1
- DCWXELXMIBXGTH-UHFFFAOYSA-N phosphotyrosine Chemical compound OC(=O)C(N)CC1=CC=C(OP(O)(O)=O)C=C1 DCWXELXMIBXGTH-UHFFFAOYSA-N 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229960000249 pregnenolone Drugs 0.000 description 1
- ORNBQBCIOKFOEO-QGVNFLHTSA-N pregnenolone Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 ORNBQBCIOKFOEO-QGVNFLHTSA-N 0.000 description 1
- HGVVOUNEGQIPMS-UHFFFAOYSA-N procyanidin Chemical compound O1C2=CC(O)=CC(O)=C2C(O)C(O)C1(C=1C=C(O)C(O)=CC=1)OC1CC2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 HGVVOUNEGQIPMS-UHFFFAOYSA-N 0.000 description 1
- 229920002414 procyanidin Polymers 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 229940125723 sedative agent Drugs 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- SUVMJBTUFCVSAD-UHFFFAOYSA-N sulforaphane Chemical compound CS(=O)CCCCN=C=S SUVMJBTUFCVSAD-UHFFFAOYSA-N 0.000 description 1
- 229960005559 sulforaphane Drugs 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229960001603 tamoxifen Drugs 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 235000020334 white tea Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/0002—Processes of manufacture not relating to composition and compounding ingredients
- A23G3/0063—Coating or filling sweetmeats or confectionery
- A23G3/0065—Processes for making filled articles, composite articles, multi-layered articles
- A23G3/007—Processes for making filled articles, composite articles, multi-layered articles the material being shaped at least partially in a mould, in the hollows of a surface, a drum, an endless band or by drop-by-drop casting or dispensing of the materials on a surface or an article being completed
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
- A23G3/364—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
- A23G3/368—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/50—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by shape, structure or physical form, e.g. products with supported structure
- A23G3/54—Composite products, e.g. layered, coated, filled
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Inorganic Chemistry (AREA)
- Mycology (AREA)
- Jellies, Jams, And Syrups (AREA)
Abstract
A method for producing a gummy with functional ingredient(s) comprising depositing a gummy base into a mold and injecting a functional ingredient solution with a temperature lower than 50℃ into the gummy base before it is fully set. Preferably, the gummy base solution comprises gelling agent(s) and it is heated to between 100-135°C before being deposited in a mould. Once the base temperature is below 95°C, the functional ingredient solution is injected into the gelling gummy base solution. Also claimed is a system for producing the gummies comprising functional ingredient container(s) 1, pump 4, for pumping the functional ingredient solution through tube 3 to a dispenser 2 comprising an array of multiple injectors 5. Each injector comprises an injection needle for dispensing a measured dose of functional ingredients into one or more jellifying gummies in a mold tray 10. Preferably, there is a second pump 8, the mould tray is on a conveyor belt 9 and the flow of solution is controlled by valves 6 and 7. The method may minimize degradation of the functional ingredients, which may be uniformly dispersed within the gummy.
Description
METHOD AND SYSTEM FOR MAKING GUMMY CONSUMABLES
CONTAINING FUNCTIONAL INGREDIENTS
FIELD OF THE INVENTION
The present invention relates to a method for producing a gummy consumable with functional ingredients.
BACKGROUND
Nutritional and dietary supplements such as multi-vitamins and minerals, botanicals and herbal extracts have grown in popularity, as evidenced by the tremendous growth in the industry involved in their manufacture, production and distribution. Such supplements can be consumed in a variety of ways, the most common being in powder or capsule form and more recently in a gummy consumable form, more commonly referred as such as gummy candies or gummies.
Gummy candy is a confectionery with a soft texture mainly made from gelatins and/or pectins to which food sweeteners, flavorings and colorants are added. In recent years gummy candy containing functional ingredients is popular because of its simplicity and taste.
Most functional ingredients are easily affected by light, heat and pH and it is often difficult to ensure the durability of the product. Depending upon the method of manufacturing the confectionery matrix, the active ingredient may suffer from deterioration or damage due to heat and/or mechanical stresses in the manufacturing process.
Producing gummies includes mixing the gummi confection ingredients such as sugar, glucose syrup, gelatin, and water, cooking the mixture to obtain a molten gelatin mixture which is then quickly poured into the molds -when still hot -and allowed to cool and set in the mold, prior to packaging or consumption. The cooking step of the gummy mixture in high temperatures is not compatible with the stability of the functional ingredients as they tend to degrade in high temperatures. Hence, the described methods for making gummies with fuctional ingredients usually chose the addition and mixing of said ingredients after the cooking step. Even in this approach, the molten gelatin mixture needs to be kept at a certain temperature around 90C and above to prevent an early setting/jellying of the mixture before it is deposited into the molds.
Inclusion of the functional ingredients further entails a modification of the solubility of the gummy ingredients and of the pH which entails a further hindrance to the final jellification of the mixture.
SUMMARY OF THE INVENTION
The present invention and embodiments thereof serve to provide a solution to one or more of above-mentioned disadvantages. To this end, the present invention relates to a method for producing a gummy consumables with functional ingredients by injecting functional ingredients into the gummy base. According to claim 1, the method comprises injecting an amount of a solution of one or more functional ingredients where the solution has a temperature of less than 50 ° C into a gelling gummy base solution which is comprising one or more gelling agents immediately after depositing the gummy base solution in a mold. The solution is injected before the finalization of the gelling process.
Injecting the functional ingredient solution into the gummy base after the deposition of the gummy base into the mold assists in a smooth deposition of the gummy base when it is still hot and in liquid form and minimizes the degradation of the functional ingredients by allowing the coiling of the base in the mold before the injection of the functional ingredients.
Preferred embodiments of the method are shown in any of the claims 2 to 12.
In a second aspect, the present invention relates to a system for producing gummies with functional ingredients according to claim 13. The system is comprising at least one liquid container suited for containing a solution of said functional ingredients, a pump, preferably a vacuum pump, for pumping at least an amount of a solution of functional ingredients from said liquid container to a dispenser, wherein said dispenser comprises an array of multiple injectors, each injector comprising an injection needle, for dispensing a measured dose of said solution of functional ingredients into one or more jellifying gummies positioned into a mold.
Preferred embodiments of the system are shown in any of the claims 14 to 17.
DESCRIPTION OF FIGURES
The following description of the figures of specific embodiments of the invention is merely exemplary in nature and is not intended to limit the present teachings, their application or uses. Throughout the drawings, corresponding reference numerals indicate like or corresponding parts and features.
Figure 1 shows a schematic representation of a system for production of gummies with functional ingredients.
DETAILED DESCRIPTION OF THE INVENTION
The present invention discloses a method for manufacturing aiming to resolve at least some of the problems and disadvantages discussed below by injecting the functional ingredients into the blend after the blend is deposited into the mold forms. Gummies have been becoming a preferred delivery system for the functional ingredients by the producers as they offer a longer shelf life to the functional ingredients compared to capsules or tablets and by the consumers due to their easy consumption and preferred taste.
Production of gummies requires heating of gummy blend to high temperatures to liquefy and deposition of the gummy blend into the mold forms while it is still in the liquid state and allow cooling for the final shape of the gummies.
Homogenous introduction of functional ingredients into gummies requires the addition of the ingredients while the gummy bled is still in the liquid state, hence hot, which leads to the degradation of the functional ingredients. One approach to solve the problem might be adding the functional ingredients after the blend is cooled down to a certain temperature. But this approach conflicts with the deposition of the gummy bled into the mold forms and molding procedure.
Definitions Unless otherwise defined, all terms used in disclosing the invention, including technical and scientific terms, have the meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. By means of further guidance, term definitions are included to better appreciate the teaching of the present invention.
As used herein, the following terms have the following meanings: "A", "an", and "the" as used herein refers to both singular and plural referents unless the context clearly dictates otherwise. By way of example, "a compartment" refers to one or more than one compartment.
"About" as used herein referring to a measurable value such as a parameter, an amount, a temporal duration, and the like, is meant to encompass variations of +/20% or less, preferably +/-100/0 or less, more preferably +/-5% or less, even more preferably +/-1% or less, and still more preferably +/-0.1% or less of and from the specified value, in so far such variations are appropriate to perform in the disclosed invention. However, it is to be understood that the value to which the modifier "about" refers is itself also specifically disclosed.
"Comprise", "comprising", and "comprises" and "comprised of" as used herein are synonymous with "include", "including", "includes" or "contain", "containing", "contains" and are inclusive or open-ended terms that specifies the presence of what follows e.g. component and do not exclude or preclude the presence of additional, non-recited components, features, element, members, steps, known in the art or disclosed therein.
Furthermore, the terms first, second, third and the like in the description and in the claims, are used for distinguishing between similar elements and not necessarily for describing a sequential or chronological order, unless specified. It is to be understood that the terms so used are interchangeable under appropriate circumstances and that the embodiments of the invention described herein are capable of operation in other sequences than described or illustrated herein.
The recitation of numerical ranges by endpoints includes all numbers and fractions subsumed within that range, as well as the recited endpoints.
The expression "Wo by weight", "weight percent", "%wt" or "wt%", here and throughout the description unless otherwise defined, refers to the relative weight of the respective component based on the overall weight of the formulation.
Whereas the terms "one or more" or "at least one", such as one or more or at least one member(s) of a group of members, is clear per se, by means of further exemplification, the term encompasses inter alia a reference to any one of said members, or to any two or more of said members, such as, e.g., any or etc. of said members, and up to all said members.
The term "gummy", "gummy candy", "gummy confectionary", "gummy consumables" are used herein interchangeably and "gummies" refers to plurality of the same terms. Gummies as used herein refers to a broad category of gelatin-based chewable consumables. Gummies may or may not be sweet. Gummies can be in a wide variety of shapes and colors.
The term "functional ingredient," as used herein, includes physiologically or pharmacologically active substances intended for use in the treatment, prevention, diagnosis, cure or mitigation of disease or illness, or substances that provide some degree of nutritional or therapeutic benefit to an animal and/or a human when consumed. The term "functional ingredient" refers more particularly to the ISLI European definition that states that a functional food can be regarded as "functional" if it is satisfactorily demonstrated to affect beneficially one or more target functions in the body, beyond adequate nutritional effects in a way that is either an improved state of health and well-being and/or reduction of risk of disease (Scientific Concept of Functional Foods in Europe: Consensus Document, British Journal of Nutrition, Volume 80, supplement 1, August 1998). Non-limiting examples include drugs, botanical extracts, enzymes, hormones, proteins, polypeptides, antigens, nutritional supplements such as fatty acids, antioxidants, vitamins, minerals, as well as other pharmaceutically or therapeutically useful compounds. The functional ingredients may include ingredients having active effects in dental or medical hygiene, bone health, digestive aid, intestinal protection, general nutrition, stress relief, etc. The term "drug," as used herein refers to a pharmacologically active substance that exerts a localized or systemic effect or effects on an animal and/or a human.
The terms "botanical extract" and "botanical," as used interchangeably herein, refer to a substance derived from a plant source. Non-limiting examples may include echinacea, Siberian ginseng, ginko biloba, kola nut, goldenseal, gob o kola, schizandra, elderberry, St. Johns Wort, valerian and ephedra.
The term "nutritional supplement" as used herein refers to a substance that exerts a physiological effect on an animal. Typically, nutritional supplements fulfill a specific physiological function or promote the health and well-being of the consumer.
The term "animal" as used herein includes, but is not limited to, mammals including humans, birds and reptiles.
The term "gelling agents", "gellants", "thickening agents", "thickeners" or "hydrocolloids" as used herein interchangeably. Suitable gelling agents can be selected by one of ordinary skill in the art. Examples include gums, carrageenan, gelatin, pectin, high methoxy pectin, alginates, and agar or agar agar. One of ordinary skill in the art can select a suitable gelling agent or hydrocolloid depending on the desired final texture of the starch molded piece. There are some gummi confections made with pectin or starch instead of gelatin, making them suitable for vegetarians.
Unless otherwise defined, all terms used in disclosing the invention, including technical and scientific terms, have the meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. By means of further guidance, definitions for the terms used in the description are included to better appreciate the teaching of the present invention. The terms or definitions used herein are provided solely to aid in the understanding of the invention.
Reference throughout this specification to "one embodiment" or "an embodiment" means that a particular feature, structure or characteristic described in connection with the embodiment is included in at least one embodiment of the present invention. Thus, appearances of the phrases "in one embodiment" or "in an embodiment" in various places throughout this specification are not necessarily all referring to the same embodiment but may. Furthermore, the particular features, structures or characteristics may be combined in any suitable manner, as would be apparent to a person skilled in the art from this disclosure, in one or more embodiments. Furthermore, while some embodiments described herein include some but not other features included in other embodiments, combinations of features of different embodiments are meant to be within the scope of the invention, and form different embodiments, as would be understood by those in the art. For example, in the following claims, any of the claimed embodiments can be used in any combination.
Description
In a first aspect, a method for producing gummies with one or more functional ingredients is disclosed. The method comprises injecting an amount of a solution of one or more functional ingredients, said solution has a temperature of less than 500 C into a gelling gummy base solution comprising one or more gelling agents after depositing said gummy base solution in a mold, wherein said the gelling process is not yet finalized when injecting.
The inventors have unexpectedly observed that the injection of the functional ingredients into the gummy base after the gummy base is deposited into the molding cavities allowed the unified distribution of the functional ingredients through the gummy base and minimized the degradation of the functional ingredients, keeping them at or close to the initial concentration that they have added to the gummy. Collectively the simple yet innovative production method as disclosed here allows the production of gummies comprising almost homogenously distributed functional ingredients with minimal to no degradation hence increased shelf life.
In embodiments, gummies produced with disclosed method comprise one or more functional ingredients that are homogenously or substantially homogenously dispersed within the gummy base. Due to the substantially uniform and complete dispersion of the functional ingredients within the gummy, the gummies are suitable for division into sub-units.
In embodiments the gummies of a batch produced with disclosed method comprise equal or substantially equal amount of one or more functional ingredients.
It is crucial for each gummy produced to have predetermined amount of said functional ingredients. In classical methods, this becomes difficult as functional ingredients are added to the gummy base before the gummy base is deposited into molds. The problem is mostly due to requirement of low temperatures for functional ingredients as they are easily degraded in high temperatures and due to the fast setting of the gummy base in low temperatures which together lead to patchy distribution of functional ingredients in the gummy base thus, gummies with uneven amount of functional ingredients when the gummy base with functional ingredients is deposited into molds or cut into smaller pieces.
According to a preferred embodiment, the method comprising the following steps: a. mixing of a gummy base solution comprising one or more gelling agents; b. heating said gummy base solution to a temperature between 100°C and 135°C; c. depositing an amount of the gummy base solution into one or more mold cavities for molding; and allowing said deposited amount to start jellifying; d. once the temperature of the gelling gummy base solution is below 95°C, injecting an amount of a solution of one or more functional ingredients into the gelling gummy base solution; and e. Demolding the gummy In embodiments, the gummy base mainly needs to contain at least one gelling agent and water or one or more sources of water.
In embodiments, one or more gelling agents are used to create texture in water-based products that would otherwise be runny. A wide variety of hydrocolloids, for example, pectin, starches or gelatin, are available as gelling agents for confectionery production. The examples of gelling agents used in some embodiments include but are not limited to gelatin, gellan, pectin, agar, cellulose, guar gum, locust bean gum, carrageenan, modified starch, xanthan gum, tragacanth, acacia gum, karaya gum, locust bean The use of gelling agents is well-known in the art and many gelling agents for use in products for human or animal consumption are available commercially, for example, Type B gelatine from Leiner Davis, Kelcogel0 Gellan Gum manufactured by CP Kelco and a range of Ticagel® hydrocoUoids from TIC Gums.
In some embodiments plant-based gelling agents are used for the production of vegetarian and/or vegan alternatives of said gummies with functional ingredients. Non-limiting examples of said plant-based gelling agents used in the embodiments include pectin, agar, starch or modified starch.
In embodiments, choice of gelling agent used may vary depending on the other ingredients of the gummy. The addition of certain ingredients can indirectly impact the pH and other characteristics of the gummy product, which in turn can have a major influence on the gelling mechanism of gelling agents. Careful selection of the right gelling agent is paramount to achieving the desired texture.
One skilled in the art will appreciate that the selection of the gelling agent to be used in the gummy base will depend on the pH of the gummy base, the interaction of the gelling agent with the carbohydrate component of the gummy base and/or the functional ingredients, and the particular texture and consistency required for the final product. The type of gelling agent used will also affect the set temperature of the matrix which may become important for the properties of the functional ingredient(s) to be incorporated into the gummy, for example functional ingredients with low stability in high temperatures are more suitable to use with the gelling agents that have a low set temperature.
In embodiments, the selection of an appropriate gelling agent is considered to be within the ordinary skills of a worker in the art.
In embodiments, the amount of the gelling agent added to the gummy base is non-limiting and varies depending on the final texture and palatability of the gummies.
In a preferred embodiment, the gummy base solution comprises a gelling agent at a level from 2 to 25% by weight of the gelling agent, more preferably from 3 to 20%, from 5 to 15%, even more specifically from 7 to 12% and all the ranges and subranges therein between.
In embodiments, the gummy compositions further comprise a variety of ingredients known to those skilled in the art.
In some embodiments, the gummy base solution further comprises other ingredients such as one or more other carbohydrates, one or more hydrocolloids, one or more pH correctors, one or more sugars, one or more substitutes of sugar, one or more sugar alcohols, one or more sugar syrups, one or more sweeteners, one or more aromas, one or more natural or artificial flavorings, one or more coloring agents or other excipients or a combination thereof.
In other embodiments, the gummy base may further comprise minerals, fruit juice and/or dairy products.
In embodiments, in the case of producing sugar-free gummies with functional ingredient substitutes of sugar is used in the gummy base.
In embodiments, any of these various optional ingredients and any other ingredients known in the art to produce gummy candies may be used to prepare the gummy base solution, and the content thereof is not particularly limited.
In embodiments any conventional method as a method for preparing the gummy base can be used. For example, a gummy base can be prepared by dissolving at least one gelling agent, and if necessary, any combination of above optional ingredients, in a liquid, e.g., water, fruit juice or milk by heating. In embodiments, gummy base may be prepared by first dissolving the gelling agent in liquid by heating to obtain an aqueous solution of gelling agent and then adding/mixing any other optional ingredients into said aqueous gelling agent solution.
Optionally, the combination is heated (heat-processed) using applied heat, a flame, or a microwave. The gummy base solution and/or aqueous gelling agent solution is boiled in hot water, e.g., stovetop boiling, the addition of boiling water to a container, or microwaving the gummy base solution along with water. In one aspect, boiling water (about 100° C.) is added to a combination of gummy base ingredients.
There is no particular limitation on the order of addition of the ingredients and the aqueous gelling solution.
In particular embodiments, for the preparation of the gummy base solution, said solution is heated to or above 90 °C, for example, said base solution is heated to 90°C, 95°C, 100°C, 110 °C, 120 °C, 130 °C, 140 °C.
In preferred embodiments, the gummy base solution is heated to a temperature between 100°C and 135°C, for example, between 105°C and 135°C, between 110°C and 135°C, between 115°C and 135°C, between 120°C and 135°C and all the ranges and subranges therein between.
In embodiments, the gummy base solution is kept at a temperature of at least 70°C and above after preparation. In embodiments a means of heating applied to the gummy base solution after its preparation to keep said solution at desired temperature.
In embodiments, the gummy base solution is at a temperature of at least 70°C when being deposited into the molds, for example, the gummy base solution is at a temperature of at least 70°C, at least 75°C, at least 80°C, at least 85°C, at least 90°C, at least 95°C, at least 100°C, at least 110°C, at least 115°C, at least 120°C, at least 125°C at least 130°C and any temperature therein between during its deposition into the molds. In preferred embodiments, the gummy base solution is at a temperature between 95°C and 110°C when being deposited into the molds.
In embodiments, the gummy base can be deposited into molds by means of pouring or injecting into molds.
Maintaining the high temperature of the gummy base during its deposition into the molds is important as the gummy base starts to set as it starts too cool down. The traditional methods for producing gummies with functional ingredients requires mixing of functional ingredients into the gummy base before the deposition of gummy base into molds. These methods, have to compromise between the most suitable gummy base temperature during the deposition and keeping the functional ingredients stable, and undegraded. Gelling agents with low setting temperature may offer an alternative but it is limiting in terms of texture and taste as not all gelling agents are compatible for any additional ingredients in the gummy base. In embodiments, the technical difference of the method allows for deposition of the gummy base into the molds at any desired temperature, including the high temperatures.
In embodiments, the gummy base solution is poured or deposited into the molds and is allowed to cool to a desired temperature prior to injection of the functional ingredients. In specific embodiments, gummy base solution is cooled down to a temperature lower than 100°C prior to injection of the functional ingredients, preferably to 95°C, 90°C, 85°C, 80°C, 75°C, 70, 65°C, 60°C, 55°C, 50°C and all the temperatures therein between.
In embodiments, the gummy base is actively cooled down to a temperature after its deposition into the molds by means of a cooling element. In embodiments said cooling element comprises a fan blowing air to the gummy base and/ or to the molds comprising the gummy base. In other embodiments, the cooling element comprises a cold block placed on and/or under the molds.
In embodiments, solution of one or more functional ingredients injected into a gelling gummy base solution comprising one or more gelling agents immediately after depositing said gummy base solution in a mold.
The addition of functional ingredients into the base solution at moderate temperatures ensures that the functional ingredients are not degraded by excessive heat.
In embodiments, the gummy base solution has a temperature between 50°C and 100°C at the time of injection of said one or more functional ingredient solutions, for example said solution has a temperature between 100°C and 95°C, 95°C and 90°C, 90°C and 85°C, 85°C and 80°C, 80°C and 75°C, 75°C and 70°C, 70°C and 65°C, 65°C and 60°C, 60°C and 55°C, 55°C and 50°C. In more preferred embodiments the gummy base solution has a temperature between 95°C and 60°C, more preferably between 90°C and 65°C,even more preferably between 90°C and 70°C, and all the ranges and subranges therein between.
One skilled in the art will appreciate that the selection of the temperature of the gummy base before and/or during the injection of the functional ingredients will depend on the nature of the functional ingredient to be used, such as a temperature below the temperature causes the degradation and/or inactivation of chosen functional ingredient as well as, the setting temperature of the gummy base.
In embodiment, the temperature of the gummy base solution at the time of the injection can be between 60 and 90°C, depending on active ingredients to be injected.
In embodiments, the functional ingredient solution is kept at a temperature between 0°C and 30°C before and/or during the injection into said gummy base solution. In a preferred embodiment, the functional ingredient solution is kept at a temperature between 4°C and 30°C, between 4°C and 25°C, between 4°C and 22°C, between 10°C and 30°C, between 15°C and 30°C, between 16°C and 28°C, between 18°C and 26°C, between 19°C and 24°C, between 19°C and 23°C, more preferably between 20°C and 22°C and all the ranges and subranges therein between.
One skilled in the art will appreciate that the nature of the functional ingredient chosen will determine the temperature that said functional ingredient is kept before the injection. In embodiments, the functional ingredient is kept at a temperature before the injection wherein said temperature is suitable for preventing the ingredient from degrading or becoming dysfunctional. For example, in specific embodiments, said functional ingredient is kept between -20°C and 0°C, in other embodiments between 0°C and 4°C and/or between 4°C and 8°C.
In embodiments, the gummies produced according to the present method comprise one or more functional ingredients. The one or more functional ingredients are selected from the group of botanicals, nutritional supplements, vitamins, minerals, enzymes, hormones, proteins, probiotics, prebiotics, drugs, polypeptides, and antigens.
In embodiments, the functional ingredients to be incorporated into the gummies can be, nutritional supplements that fulfill a specific physiologic function or promote the health and/or well-being of the consumer, botanicals or herbal extracts, and the like. 10 In some embodiments, one or more of the functional ingredients injected into gummies produced by disclosed method can be a nutritional supplement. Illustrative, but non-limiting, examples of nutritional supplements suitable for use with the delivery system according to the present invention include, probiotic bacteria, prebiotics, vitamins, enzymes, co-enzymes, cofactors, antioxidants, minerals and mineral salts, amino-acids and amino acid derivatives (for example, dimethylglycine), peptides, proteins, gums, carbohydrates, phytochemicals, dextroses, phospholipids, other trace nutrients, oxygenators, brain-stimulating substances, energy providers, metabolic intennediates, hormones, botanical extracts, fatty acids (for example, linoleic acid or conjugated linoleic acid), oat beta-glucan or other functional fibres, carnitine, bicarbonate, citrate, or combinations thereof.
In embodiments, probiotic microorganisms in the form of live microbial nutritional supplements and which are recognized as conferring a beneficial effect on an animal can be incorporated in the gummies produced by disclosed method. Probiotic microorganisms are microorganisms which beneficially affect a host by improving its intestinal microbial balance. Beneficial effects of probiotic microorganisms include activation of the immune system, prevention of the bacterial overgrowth by pathogens, prevention of diarrhoea and/or restoration of intestinal flora. Examples of probiotic microorganisms include, but are not limited to, Bifidobacterium (such as Bifidobacterium longum B129, Bifidobacterium longum B128, Bifidobacterium adolescentis Bad4, and Bifidobacterium lactis Bb12), Lactobacillus (such as, Lactobacillus johnsonii and Lactobacillus paracasei), Streptococcus and Saccharomyces.
In embodiments, the amount of probiotic incorporated into the gummy will vary according to the specific needs. In preferred embodiments, the amount of lactic acid bacteria in one gummy can be between 108 and 1012 count/gram, for example, between 107 and 1011 count/gram, or between 108 and 1010 count/gram.
In embodiments prebiotics can be incorporated into the gummy base alone or in combination with probiotic bacteria. Prebiotics comprise carbohydrates, generally oligosaccharides, and have the ability to resist hydrolysis by enzymes in the animal digestive tract and thus can reach the colon undegraded to provide a carbohydrate substance particularly suited to growth of probiotic bacteria. Oligosaccharides may be produced from glucose, galactose, xylose, maltose, sucrose, lactose, starch, xylan, hemicellulose, inulin, or a mixture thereof. Purified commercially available products such as fructooligosaccharide contain greater than about 95% solids in the form of oligosaccharides. Prebiotics often comprise a mixture of fructooligosaccharide and inulin, for example, PREBI01"7) or a mixture of commercially available RAFTILOSEE and RAFTILINE® commercialized by Orafti. A prebiotic of this kind has been demonstrated to improve the response of the immune system.
In other embodiments, suitable nutritional supplements include vitamins and minerals that the body is usually not capable of synthesizing, and which are necessary for ensuring normal growth and/or daily body maintenance. In the context of the present discloser, the vitamins can be hydrosoluble or liposoluble vitamins. Examples includes, but are not limited to, Vitamin A (axerophtol or retinol), Vitamin D, Vitamin E (alpha-tocopherol), Vitamin K, Vitamin B and/or PP (niacinamide or nicotinic acid amide) and Vitamin C (L-ascorbic acid).
The dosage of vitamins in the gummies produced with disclosed method can be adapted to specific needs. In a general but not-limiting example, one gummy may contain a fraction of the recommended daily amount (RDA) of the desired vitamin.
For example, assuming a daily consumption of five gummies, and following European RDA recommendations, Vitamin A can be used up to 160 pg typically between 70 pg and 90 pg a single gummy; Vitamin C up to 12 mg typically between 5 mg and 7 mg a single gummy; Vitamin E up to 2 mg typically between 0.8 mg and 1.2 mg a single gummy; Vitamin D up to 1 pg typically between 0.4 pg and 0.6 pg a single gummy; Vitamin BI up to 0.28 mg typically between 0.12 mg and 0.15 mg a single gummy.
In embodiments, antioxidants can be incorporated into the gummies produced according to the present invention, alone or in combination with other functional agents, such as glutathione, peroxidase, superoxide dismutase, catalase, co-enzyme Q10, honey tocopherols and other tocopherols, lycopenes, beta-carotene or other carotenoids, quertin, rutin, flavonoids, catechins, anthocyanes, eleutherosides and ginsenosides. Some of these antioxidants may be found in significant amounts in plant extracts. Examples include Ginko Biloba leaves that contain Gingko flavanoids, Blueberry fruits that contains anthocyanids, Ginseng roots which contains ginsenosides, Eleutherococcus roots which contains eleutherosides. The biologically active agent may also be a phytochemical such as polyphenol, procyanidin, phenolic acid, catechin or epicatechin, isoflavone, terpene or other phytonutritive plant material.
In embodiments, another suitable example of functional ingredients is minerals.
Minerals include macro-nutrients such as sodium, potassium, calcium, magnesium, phosphorus or oligo-elements such as iron, zinc, copper, selenium, chromium, iodine or a combination thereof. Macro-nutrients are known to play an essential role in complex metabolisms of the body such as in cellular cation exchange, for example, calcium is an essential constituent of the skeleton.
In embodiments, functional ingredients can be chosen from trace elements which are minerals present in the human body in a quantity of usually less than 5 g. An example of a trace element is zinc, which has antioxidant properties, helps in the synthesis of metallothionein, is an essential factor for protein synthesis and helps improve the function of the immune system.
In embodiments, an amount of zinc for example can be incorporated into the gummies following EU RDA recommendations. Selenium is also an antioxidant and is a co-factor for glutathione peroxidase. Selenium is known to contribute to the integrity of muscles and sperm and also plays a role in hepatic metabolism. Selenium deficiencies may lead to sever cardiac, bone or neuromuscular damage. For example, following the European RDA recommendations, an amount Selenium may be incorporated into the gummies.
Other nutritional supplements that might be suitable to use as functional ingredients according to the method include amino acids, di-peptides or polypeptides or proteins or essential fatty acids. A specific suitable example of an amino acid is glutamine which provides fuel to gastro-intestinal and immune cells, reduces bacterial translocation and helps prevent muscle loss and improves nitrogen balance. Examples of peptides are the glycopeptides of lactic origin active in inhibiting the adhesion of the bacteria responsible for dental plaque and caries. More particularly, dental and anti-plaque caries agents of this type comprise active principle(s) selected from kappa-caseino-glycopeptides and deacylated derivatives thereof (also known as "CGMP"). Such active principles have an effectiveness on the dental plaque only after a few seconds in the mouth. Other peptides include phosphopeptides or salts thereof having anticarie properties such as those having from 5 to 30 amino acids including the sequence A-B-C-D-E where, A, B, C, D and E being independently phosphoserine, phosphothreonine, phosphotyrosine, phosphohistidine, glutamate and aspartate and compositions particularly compositions to teeth including same. Other examples of polypeptides are cysteine, acetylcysteine, cysteine methionine or a combination thereof. Cysteine and its derivatives are known to aid in defence against oxidative stress and in protein synthesis.
Other nutritional supplements that are suitable to use as functional ingredient according to the present discloser include creatine, caffeine, bee pollen, Royal jelly, chitosan, chondroitin, functional fibres, phospholipids, enzymes known to aid digestion (such as papain, bromelain and lipases), shark cartilage extracts, glucosamine, methylsulponylmethane (MSM), pregnenolone, Brewer's yeast, blue green algae, omega 3, collogen and the like.
In embodiments, the nutritional supplement to be used according to present method can be a botanical extract, such as guarana, Gingko biloba, kola nut, goldenseal, Goto kola, schizandra, elderberry, St. John's Wort, valerian and ephedra and ephedra alkaloids, evening primrose oil, beta-sitosterol, cafestol, D-limonene, kabweol, nomilin, oltipraz, sulphoraphane, tangeretin, black tea, white tea, java tea, folic acid, garlic oil, fibre, jojoba, bitter melon, green tea extract, lemon oil, mace, licorice, menthol, onion oil, orange oil, rosemary extract, milk thistle extract, Echinacea, Siberian ginseng or Panax ginseng, lemon balm, Kava Kava, Yerba Mat, bilberry, soy, grapefruit, seaweed, hawthorn, lime blossom, sage, clove, basil, curcumin, taurine, wild oat herb, dandelion, gentian, aloe vera, hops, cinnamon, peppermint, grape chamomile, fennel, marshmallow, ginger, slippery elm, cardamon, coriander, anise, thyme, rehmannia, eucalyptus, menthol, citrus aurantium and schisandra.
In specific embodiments, the functional ingredients to be incorporated into the gummies can be drugs, therapeutic and/or diagnostic compounds. Representative examples include, but are not limited to, anti-tumour compounds such as tamoxifen, doxyrubicin, taxol, cisplatin; anti-viral compounds such as ddl and ddA, anti-inflammatory compounds such as NSAIDs and steroids; antibiotic compounds such as antifungal and antibacterial compounds; cholesterol lowering drugs, anti-hypertensive drugs, vasoconstrictors, sedatives, antihistamines, decongestants, expectorants, and anti-nauseants and contrast agents for medical diagnostic imaging.
Selection of appropriate functional ingredients for incorporation into the gummies for administration to a given animal or a human is considered to be within the ordinary skills of a worker in the art and it is understood that functional agents suitable for administration to humans may differ from those suitable for other animals. Furthermore, it will be apparent that inappropriate combinations of functional agents, for example, those that interact with each other, should not be included in the same gummy.
In embodiments, gummies with functional ingredients produced according to the present disclosure may contain specific combinations of any of the functional ingredients as discussed above. A wide variety of such combinations of functional ingredients are known in the art for providing specific physiological benefits and are suitable for inclusion in a gummy produced according to the invention.
In embodiments, a solution of one or more functional ingredients is preferred by dispersing said functional ingredients in a liquid.
In embodiments, said liquid is an aqueous solvent such as water or fruit juice.
In other embodiments, said liquid is an organic solvent such as oil wherein said oil can be of plant origin and/or animal origin.
In embodiments, the amount of functional ingredients in said functional ingredient solution is adjusted and vary depending on the desired concentration of functional ingredients in the final product wherein said final product is gummy with functional ingredients.
In embodiments, the volume of solution of one or more functional ingredients injected into the gummy base varies depending on the concentration of the functional ingredients in said solution.
In embodiments, the volume of solution of one or more functional ingredients injected into the gummy base varies depending on the desired concentration of functional ingredients in the final product wherein said final product is gummy with functional ingredients.
In embodiments, the volume of the solution of functional ingredient injected into the gummy base can be up to 40% by volume of the final product, the gummy produced by the disclosure. In embodiments, the volume of the functional ingredients injected can be 35%, 30%, 25%, 20%, 15%, 10%, 50/0, 1% by volume of the final product. For example, in preferred embodiments, a gummy may comprise 1 part of the solution of functional ingredients and 3 parts gummy base.
In embodiments, the solution of one or more functional ingredients may further comprise one or more other excipients. In embodiments, said further excipients can be chosen from non-limiting examples of aromas and/or coloring agents.
In embodiments, the solution of one or more functional ingredients may further comprises one or more other carbohydrates, hydrocolloids, sugars, sugar alcohols, sugar syrups, sweeteners, pH correctors, aromas, natural or artificial flavorings, coloring agents or other excipients or any combination thereof.
In embodiments, functional ingredients are incorporated into the gummy at levels sufficient to affect the structure or function of the body when taken regularly. Such levels are known in the art or can readily be determined by a skilled technician. It is understood that the total daily intake may be based on the administration of one unit of the gummy with functional ingredients, or it may be based on the administration of more or less than one unit. The amount of functional ingredients in the final product will thus vary depending on the format of the units and the number to be administered daily.
In embodiments, the weight of one or more functional ingredients is up to 40% of the total weight of a gummy. In embodiments, the weight of the functional ingredients injected can be 35%, 30%, 25%, 20°k, 15%, 10°/o, 5%, 1%, and all the ranges therein by weight of the final product.
In preferred embodiments, the functional ingredient content of the produced gummy can be up to a quarter of said gummy, such as 1 part functional ingredient and 3 parts gummy base such as, the total amount of functional ingredients constitutes up to about 25% by weight of the final product, gummy, produced by the disclosure. In embodiments of the present invention, the total amount of functional ingredients constitutes up to 1%, 5%, 10%, 15%, 20% or 25% by weight of a produced gummy.
In another preferred embodiment, the total amount of functional ingredients constitutes between 5% and 25% by the weight of a gummy.
In embodiments, molding of gummy is performed by using a Mogul process or by injection-filling of pre-formed molds. One skilled in the art will appreciate that the gummy mix can also be readily adapted to extrusion methods.
Gummies or gummy candies are typically manufactured by the Mogul system in which starch molds are formed by making a plurality of depressions of the desired shape in a bed of starch. In the Mogul system, the ingredients are blended at the appropriate temperature and then the liquid mixture is deposited into each starch mold cavity, which forms the confection and helps to reduce the moisture content.
The deposited confections are typically dried for about 12-72 hours to reach the desired moisture content of about 10% to 30% by weight. Gummies can also be manufactured by injection-filling packages or mold cavities pre-formed into an appropriate size and shape with the liquid mixture and allowing the mixture to set up. The gelled starch molded food pieces (gummies) are then removed from the trays, the starch is recycled.
In embodiments of the discloser, gummy base is deposited into mold according to any of the procedures known in the art. In embodiments, the solution of one or more functional ingredients injected into the gummy base that is deposited into the mold. In embodiments, the gelled molded gummies are then removed from the trays.
In embodiments, pH correctors can be added to the gummy base and/or functional ingredient solution before or after the injection of solution of functional ingredients into the gummy base. pH is important for solubility of the mass such as ingredients of gummy base or functional ingredients. It will be readily apparent to one skilled in the art that pH of the gummy base solution and/or said solution of functional ingredients may vary based on the ingredients that are added to the solutions. pH entails a further importance in the final jellification of the mixture.
In embodiments, the pH of gummy base solution has a pH between 2.0 and 8.5, for example between 2 and 5, between 5 and 8.5, between 3 and 7, and all the ranges and subranges therein between.
In embodiments the pH of the solution of functional ingredients has a pH between 2.0 and 8.5, for example between 2 and 5, between 5 and 8.5, between 3 and 7, and all the ranges and subranges there in between.
In embodiments, further pH correctors are added to the gummy base solution and/or solution of one or more functional ingredients and/or to the final gummy mix comprising gummy base and solution of one or more functional ingredients with the aim of reaching a desirable pH of the final mixture and not hindering the gelling.
In embodiments, the final gummy mix comprising gummy base and solution of one or more functional ingredients has a pH between 2.0 and 8.5, for example between 2 and 5, between 5 and 8.5, between 3 and 7 and all the ranges and subranges there in between.
In a second aspect, the present invention relates to a system for producing gummies with functional ingredients. The system comprises at least one liquid container, a pump, and at least one dispenser, wherein said at least one dispenser comprises an array of multiple injectors, for dispensing a measured dose of said solution of functional ingredients into one or more jellifying gummies positioned into a mold.
In embodiments, the system comprises at least one liquid container suited for containing a solution of said functional ingredients, a pump, preferably a vacuum pump, for pumping at least an amount of a solution of functional ingredients from said liquid container to a dispenser, wherein said dispenser comprises an array of multiple injectors, each injector comprising an injection needle, for dispensing a measured dose of said solution of functional ingredients into one or more jellifying gummies positioned into a mold.
In embodiments, the liquid container and the dispenser of said system is in fluid connection.
In embodiments, the system comprises a conveyor for transporting molds with jellifying gummies to the dispenser. In embodiments the conveyor is located under the dispensers and molds with jellifying gummies are transported under the dispenser by said conveyor, preferably where each mold cavity is positioned under one injector of the dispenser.
In embodiments, the dispenser can move horizontally and vertically. The movement of the dispenser allows the desired positioning of each injector above a mold cavity.
In embodiments, the injector needle have an inside diameter of 0.5 mm to 3.5 mm. For example, the injector needles have an inside diameter of 0.5 mm to 3 mm, 0.75 15 mm to 3mm, 1 mm to 3 mm, 1 mm to 2 mm, 2 mm to 3 mm and all the ranges and subranges therein between.
In embodiments, the number of the injectors and the orientation of said injectors of said dispenser is variable. In some embodiments, said dispenser may have total of 5 injectors, 10 injectors, 20 injectors or 100 injectors. In other embodiments, said dispenser may have total of 20 injectors distributed in ten rows (10x2), in another embodiment, said total of 20 injectors may be distributed in 4 rows (4x5).
In embodiments, the system further comprises a second dispenser for depositing gummy base liquid into the mold cavities.
In further embodiments, the system further comprises a heating element such as a heater to regulate and/or maintain the gummy base at a desired temperature.
In embodiments, the heating element can be used to regulate the temperature of the gummy base before, during, and/or after its deposition into the molds or mold cavities.
In further embodiments, the system further comprises a cooling element to cool down the gummy base at a desired temperature after its deposition into the molds.
In embodiments, the cooling element comprises a fan and/or cold block.
In embodiments, the disclosed device further comprises one or more vacuum pumps that are activatable for aspirating liquid from at least one liquid container.
In embodiments, the disclosed device further comprises one or more sensors. Example of sensors includes but not limited to motion sensors, light sensor, probes, float switch, or turning fork.
In embodiments, the sensors can be used for the determination of liquid volumes. In preferred embodiments, sensors are used for the determination of liquid volumes in the liquid containers and/or for the determination of liquid volume ejected from injectors and/or for the determination of the liquid volume in each mold cavity.
In embodiments, sensors are used for the determination of the position of injectors, for example for the correct positioning of the injectors above the mold cavities.
In embodiments, the disclosed device further comprises a CPU for the automated transfer of liquids from the liquid containers to at least one liquid dispenser and to molds or a combination thereof.
In another embodiment, the ejection of liquid from the injectors is controlled by programmable electromagnetic valves.
In an embodiment, all injectors eject liquid into the mold cavities simultaneously.
In another embodiment, only a selection of the injectors ejects liquid into the mold cavities.
The invention is further described by the following non-limiting examples which further illustrate the invention, and are not intended to, nor should they be interpreted to, limit the scope of the invention.
EXAMPLES and/or DESCRIPTION OF FIGURES
The present invention will now be further exemplified with reference to the following examples. The present invention is in no way limited to the given examples or to the embodiments presented in the figures.
Example 1: Preparation of a solution containing vitamin C Vitamin C solution is prepared by dissolving 10 gr of ascorbic acid in 100 ml water.
Example 2: Production of gummies comprising vitamin C A gummy base was prepared with ingredients % by weight: corn syrup 55%, glycerol 20%; 7.5% gelatin, and 17.5% of water, total 100%. Ingredients were mixed, and the mixture was heated to 100 ° C to allow the components to dissolve. The obtained gummy base was kept at 90 ° C and 4.5 ml of the gummy base was filled into a hemispherical recessed starch mold. Immediately after the deposition into the mold, 0.5 ml of vitamin C solution in room temperature, prepared in Example I, was injected into the gummy base, yielding a gummy mix with a total volume of 5 ml comprising 50 mg of vitamin C. Gummy mixture was allowed to dry at 40 ° C for 48 hours and the gummies with vitamin C were demolded.
Example 3: Analysis of the stability of the vitamin C and its uniform distribution in produced gummy In order to examine the stability of vitamin C in the gummy that was produced according to Example 2, the gummy candy was cut into 5 equal pieces and dissolved in 100m1 of distilled water and the content of vitamin C in the gummy candy was determined by high performance liquid chromatography (HPLC). The percentage of Vitamin C (by weight) was determined by comparing the mean response of Vitamin C in each sample to the mean response of a stock solution at known concentrations.
The mean percentage Vitamin C by weight for the samples was about 9 %. This is consistent with the expected amount of 10 % of Vitamin C in the final product.In order to confirm the uniform dispersion of vitamin C content within the gummy base, vitamin Content of each piece from a gummy compared to each other. Results showed a similar distribution with +/-10 % deviation.
The analysis were carried out for 10 randomly picked gummies per batch to confirm the same or significantly similar vitamin C content among the gummies produced in a single batch. Results showed a similar distribution with +/-5 % deviation.
It is supposed that the present invention is not restricted to any form of realization described previously and that some modifications can be added to the presented example of fabrication without reappraisal of the appended claims. For example, the present invention has been described referring to gummies with vitamin C, but it is clear that the invention can be applied to production of gummies with any other functional ingredients.
FIGURE DESCRIPTION
Figure 1 shows a schematic drawing of an embodiment of a production system for gummies with functional ingredients. The system shown comprises a liquid container (1), a dispenser (2) with an array of multiple injectors (5), tubing for fluid connection (3), a vacuum pump (4), electronic valves (6 and 7), a second pump (8), conveyor (9) and a tray (10).
A solution of functional ingredients is held in a liquid container (1). The liquid container (1) is in fluid connection with said dispenser (2) via tubing (3). A vacuum pump (4) is used for pumping at least an amount of a solution of functional ingredients from said liquid container to said dispenser. Said solution of functional ingredients is fed to the dispenser is then ejected out from said an array of injectors (5). The electronic valves (6 and 7) are used to control the flow of said solution. A conveyor belt (9) is placed beneath the dispenser to transfer and position trays (10) under said injectors wherein said trays are comprising jelling gummy base in the molding cavities.
It is clear that the method according to the invention, and its applications, are not limited to the presented examples.
Claims (17)
- CLAIMS1. A method for producing gummies with one or more functional ingredients, said method comprises injecting an amount of a solution of one or more functional ingredients, said solution has a temperature of less than 50 ° C, into a gelling gummy base solution comprising one or more gelling agents after depositing said gummy base solution in a mold, wherein said the gelling process is not yet finalized when injecting.
- 2. The method according to claim 1, comprising the following steps: a. mixing of a gummy base solution comprising one or more gelling agents; b. heating said gummy base solution to a temperature between 100°C to 135 °C.c. depositing an amount of the gummy base solution into one or more molds for molding; and allowing said deposited amount to start jellifying; d. once the temperature of the gelling gummy base solution is below 95°C, injecting an amount of a solution of one or more functional ingredients into the gelling gummy base solution; and e. Demo!ding the gummy
- 3. The method according to any of the previous claims, wherein said gummy base solution is at a temperature of at least 70°C during its deposition into molds.
- 4. The method according to any of the previous claims, wherein said gummy base solution is actively cooled down to a predetermined temperature after the deposition of said solution into the molds and prior to injection of the functional ingredients into the said solution.
- 5. The method according to any of the previous claims, wherein said gummy base solution has a temperature between 50°C and 90°C at the time of injection of said one or more functional ingredient solution.
- 6. The method according to any of the previous claims, wherein said functional ingredient solution is kept at a temperature between 0°C and 30°C prior to and/or during the injection into said gummy base solution.
- 7. The method according to any of the previous claims, wherein said one or more gelling agents are chosen from gelatin, gellan, pectin, agar-agar, cellulose, one or more starches or their derivatives and/or any combination thereof.
- 8. The method according to any of the previous claims, wherein said one or more functional ingredients are selected from the group of botanicals, nutritional supplements, vitamins, minerals, enzymes, hormones, proteins, probiotics, prebiotics.
- 9. The method according to any of the previous claims, wherein said solution of one or more functional ingredients is prepared by dispersing said one or more functional ingredients in a liquid, preferably in water or oil.
- 10. The method according to any of the previous claims, wherein said solution of functional ingredients further comprises other excipients such as aromas and/or coloring agents.
- 11. The method according to any of the previous claims, wherein said base solution further comprises one or more other carbohydrates, sugars, sugar alcohols, sugar syrups, sweeteners, pH correctors, aromas, natural or artificial flavorings, coloring agents or any combination thereof.
- 12. The method according to any of the previous claims, wherein the weight of functional ingredient is up to 4 0 % of the total weight of a gummy.
- 13.A system for producing gummies with functional ingredients, wherein said system comprises at least one liquid container suited for containing a solution of said functional ingredients, a pump, preferably a vacuum pump, for pumping at least an amount of a solution of functional ingredients from said liquid container to a dispenser, wherein said dispenser comprises an array of multiple injectors, each injector comprising an injection needle, for dispensing a measured dose of said solution of functional ingredients into one or more jellifying gummies positioned into a mold.
- 14. The system according to claim 13, wherein said injection needle has an inside diameter of 0.5 mm to 3 mm.
- 15.The system according to claims 13 or 14, wherein the system comprises a conveyor for transporting molds with jellifying gummies to the dispenser.
- 16.The system according to claims 13, 14 or 15 wherein the system comprises a second dispenser for depositing said gummy base liquid into the mold cavities, and a heating element to regulate or maintain the temperature of said gummy base liquid and optionally a cooling element to cool down the gummy base deposited into the molds.
- 17.The system according to claims 12, 13, 14 or 15 further comprises one or more sensors for the determination of liquid volumes; a CPU for the automated transfer of liquids from the liquid reservoirs to at least one liquid dispenser and to mold forms or a combination thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2218250.5A GB2625089A (en) | 2022-12-05 | 2022-12-05 | Method and system for making gummy consumables containing functional ingredients |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2218250.5A GB2625089A (en) | 2022-12-05 | 2022-12-05 | Method and system for making gummy consumables containing functional ingredients |
Publications (2)
Publication Number | Publication Date |
---|---|
GB202218250D0 GB202218250D0 (en) | 2023-01-18 |
GB2625089A true GB2625089A (en) | 2024-06-12 |
Family
ID=84926591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2218250.5A Pending GB2625089A (en) | 2022-12-05 | 2022-12-05 | Method and system for making gummy consumables containing functional ingredients |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2625089A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150010674A1 (en) * | 2011-09-30 | 2015-01-08 | Universidad Miguel Hernandez De Elche | Probiotic or symbiotic gelled products and method for the production thereof |
US20210360941A1 (en) * | 2020-05-22 | 2021-11-25 | Tyler D'Spain | Process for manufacturing confection with reduced aftertaste |
WO2022090438A1 (en) * | 2020-10-30 | 2022-05-05 | Rousselot Bv | Method for producing centre filled gummies comprising fillings |
-
2022
- 2022-12-05 GB GB2218250.5A patent/GB2625089A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20150010674A1 (en) * | 2011-09-30 | 2015-01-08 | Universidad Miguel Hernandez De Elche | Probiotic or symbiotic gelled products and method for the production thereof |
US20210360941A1 (en) * | 2020-05-22 | 2021-11-25 | Tyler D'Spain | Process for manufacturing confection with reduced aftertaste |
WO2022090438A1 (en) * | 2020-10-30 | 2022-05-05 | Rousselot Bv | Method for producing centre filled gummies comprising fillings |
Also Published As
Publication number | Publication date |
---|---|
GB202218250D0 (en) | 2023-01-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7531192B2 (en) | Delivery systems for functional ingredients | |
US20070196496A1 (en) | Delivery systems for functional ingredients | |
CA2981759C (en) | Multicomponent gummy compositions with soft core | |
US20040052852A1 (en) | Carbohydrate-based delivery system for creatine and other bioactive ingredients | |
AU2003213912A1 (en) | Delivery systems for functional ingredients | |
EP2642875B1 (en) | Jelly confectionery products having a stabilizer/fiber blend | |
US20120035277A1 (en) | Liquid-filled chewable supplement | |
US20120015075A1 (en) | Chewable supplement with live microorganisms | |
NZ523806A (en) | Confectionery product containing active ingredients | |
US20120164134A1 (en) | Sugar-free chewable supplement | |
US20100330058A1 (en) | Chewable drug | |
US20160279058A1 (en) | Protein-based gel delivery system | |
US8440219B2 (en) | Reduced-odor thiol compositions | |
WO2017120535A1 (en) | Food based delivery of cannabinoids | |
US20160015777A1 (en) | Protein Delivery System and Method of Making Same | |
WO2012092391A1 (en) | Method for adding heat sensitive ingredients to chewable supplements | |
WO2003026438A1 (en) | A carbohydrate-based delivery system for creatine and other bioactive ingredients | |
US20080160086A1 (en) | Delivery Systems For Calcium | |
GB2625089A (en) | Method and system for making gummy consumables containing functional ingredients | |
US20130004604A1 (en) | Dark chocolate delivery system for a combination of dietary supplements and pharmaceuticals | |
BE1031104B1 (en) | METHOD AND SYSTEM FOR MAKING GUMMY CONSUMPTION ARTICLES INCLUDING FUNCTIONAL INGREDIENTS | |
WO2012173587A1 (en) | Sugar-free chewable supplement | |
KR20150030411A (en) | Kyeongokko truffle composition and the methode for producing thereof | |
CA3226279A1 (en) | Gummy dosage forms | |
CA3215839A1 (en) | Ingestible cannabis articles and related methods and systems |